JamesR.BosscherMD

Oncology • Neptune, NJ

Gynecologic Cancer

Obstetrics/Gynecology - Gynecologic Oncology Meridian Medical Group - Faculty Practice

Join to view full profile

Dr. Bosscher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bosscher's full profile

Already have an account?

Office
19 Davis Avenue
Neptune, NJ 07753
Phone+1 732-897-7944

Fax+1 732-922-8264
Is this information wrong?

Education & Training

National Capital ConsortiumResidency, Obstetrics and Gynecology, 1988 - 1993
Tripler Army Medical CenterResidency, Obstetrics and Gynecology, 1979 - 1983
Wayne State University School of MedicineClass of 1979

Certifications & Licensure

NJ State Medical License 2015 - 2025
OH State Medical License 2015 - 2017
PA State Medical License 2010 - 2016
KY State Medical License 1993 - 2000
MD State Medical License 1988 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Start of enrollment: 2010 Nov 01
Completed
Phase 2
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms Start of enrollment: 2011 Jul 01
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

67 citations
Sunitinib Malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
Martee L. Hensley, Michael W. Sill, Dennis R. Scribner, Jubilee Brown, Robert Debernardo, Ellen M. Hartenbach, Carolyn K. McCourt, James R. Bosscher, Paola A. Gehrig> ;Gynecologic Oncology. 2009 Dec 1
7 citations
Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.
James R. Bosscher, Cicek Gercel-Taylor, Christopher S. Watkins, Douglas D. Taylor> ;Gynecologic Oncology. 2001 May 1
2 citations
Murine Intestinal Crypt Survival after Combined Taxol plus Radiation Exposure
S.L. Lojun, C.P. Sigdestad, A.M. Connor, William J. Spanos, James R. Bosscher> ;Gynecologic Oncology. 1996 Nov 1
20 citations
Vulvar eccrine porocarcinoma.
Ward A. Katsanis, David L. Doering, James R. Bosscher, Dennis M. O'Connor> ;Gynecologic Oncology. 1996 Sep 1
6 citations
Late Presentation of an α-Fetoprotein Secreting Isolated Large Upper Abdominal Retroperitoneal Sertoli-Leydig Cell Tumor Recurrence
John H. Farley, Robert R. Taylor, James Bosscher> ;Gynecologic Oncology. 1995 Feb 1
81 citations
Squamous Cell Carcinoma Antigen: Clinical Utility in Squamous Cell Carcinoma of the Uterine Cervix
Jo-Ann N. Bolli, David L. Doering, James R. Bosscher, Thomas G. Day, C V Rao, Keith J. Owens, Beverly A. Kelly, Jane Goldsmith> ;Gynecologic Oncology. 1994 Nov 1
7 citations
Clinical stage IB endometrial adenocarcinoma with an isolated small bowel metastasis.
James Bosscher, Danny Barnhill, Dennis M. O'Connor, Robert C. Park> ;Gynecologic Oncology. 1994 Jan 1
8 citations
Radical vulvectomy with partial rectal resection and temporary colostomy as primary therapy for selected patients with vulvar carcinoma
Steven Remmenga, Danny Barnhill, John D. Nash, James Bosscher, Michael Teneriello, Robert C. Park> ;Obstetrics and Gynecology. 1992 Jun 1
8 citations
Indwelling epidural catheters for pain control in gynecologic cancer patients.
Mark Shaves, Danny Barnhill, James Bosscher, Steven W. Remmenga, Marc B. Hahn, Robert C. Park> ;Obstetrics and Gynecology. 1991 Apr 1
13 citations
A technique for managing terminally III ovarian carcinoma patients
Carla Chapman, James Bosscher, Steven Remmenga, Robert C. Park, Danny Barnhill> ;Gynecologic Oncology. 1991 Apr 1
9 citations
Intestinal surgery performed on gynecologic cancer patients
Danny Barnhill, David Doering, Steven Remmenga, James Bosscher, John D. Nash, Robert C. Park> ;Gynecologic Oncology. 1991 Jan 1
21 citations
Osseous metaplasia in ovarian papillary serous cystadenocarcinoma
James Bosscher, Danny Barnhill, Dennis M. O'Connor, David Doering, John D. Nash, Robert C. Park> ;Gynecologic Oncology. 1990 Nov 1
3 citations
Adrenal phasing of a diurnal rhythm of testicular responsiveness to FSH in chickens
Jerry W. Dusseau, James R. Bosscher> ;General and Comparative Endocrinology. 1976 Mar 1
Ovarian management during radical hysterectomy in the premenopausal patient.
Parker, M., Bosscher, J., Barnhill, D., Park, R.> ;Obstet Gynecol. 1993 Aug
Viable term pregnancy with active syphilis, pelvic tuberculosis, and Pott's disease: report of case.
Shaw, C. T., Spencer, R. A., Bosscher, J. R.> ;J Am Osteopath Assoc. 1983 Nov
Join now to see all

Press Mentions

Meridian Cancer Care Team Welcomes James Bosscher, M.DFebruary 12th, 2016

Hospital Affiliations

Hackensack Meridian Health Southern Ocean Medical CenterManahawkin, New Jersey